Sponsored Content

How modern shatavari is rewriting the women’s health playbook with clinical evidence

10 Apr 2026

Xeya Modern Shatavari is not just another botanical extract—it’s a clinically validated system supported by patient-reported outcomes, physician assessments, biomarker analysis, and physical measurements.

Reengineering a classic botanical

Xeya Modern Shatavari represents a modern reengineering of this classic botanical. It contains high levels of bioactive compounds that are efficiently captured using advanced extraction technologies.

The result is a highly potent material. Xeya Modern Shatavari is standardised to 15% shatavarins, while commodity commercial extracts typically range between 5% and 6%. That high standardisation level of bioactive phytochemicals in Xeya Modern Shatavari translates to lower doses—and clinical validation in multiple human studies using doses of either 50 mg or 100 mg demonstrates its efficacy at that low dose.

Low dose, high impact

Most shatavari ingredients on the market require doses of 300 mg to 500 mg per serving. Xeya Modern Shatavari delivers comparable—or superior—outcomes at as little as one-fifth of the dose. For formulators, that changes everything.

Women’s health redefined

Hormonal balance is not the end goal. It’s the means.

Women are not waking up thinking, “Today I want balanced follicle-stimulating hormones and luteinising hormones.” They’re thinking about whether they’ll have the energy to lead a meeting, the clarity to focus, the confidence to show up fully in their relationships—or whether hot flashes, brain fog, irregular cycles, or skin issues will hijack the day.

Xeya Modern Shatavari offers something rare in this category: low dose, more flexibility, real clinical proof.

Because hormonal health isn’t the goal. Freedom is.

Read More